Showing results (261-270 of 675) with videos related to
Sort By:
Pageof 68
Cancer Prevention Research (Philadelphia, Pa.)|April 29, 2010
Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancerRobert J Klein, Christer Halldén, Angel M Cronin, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2020
Inherited Rare, Deleterious Variants in ATM Increase Lung Adenocarcinoma RiskMyvizhi Esai Selvan, Marjorie G Zauderer, Charles M Rudin, et al.Breast Cancer Research and Treatment|January 23, 2019
Customized breast cancer risk assessment in an ambulatory clinic: a portal for identifying women at riskAnna Weiss, Samantha Grossmith, Danielle Cutts, et al.Future Oncology (London, England)|October 15, 2016
A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationaleSteven J Isakoff, Shannon Puhalla, Susan M Domchek, et al.Breast Cancer Research and Treatment|April 23, 2010
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomyLori J Pierce, Kelly-Anne Phillips, Kent A Griffith, et al.Cancer|June 11, 2005
Ovarian carcinoma screening in women at intermediate risk: impact on quality of life and need for invasive follow-upNoah D Kauff, Karen E Hurley, Martee L Hensley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Fallopian tube and primary peritoneal carcinomas associated with BRCA mutationsDouglas A Levine, Peter A Argenta, Cindy J Yee, et al.European Journal of Human Genetics : EJHG|April 29, 2018
The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing resultsYvonne Bombard, Marc Clausen, Chloe Mighton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2017
Discrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer PatientsYuebi Hu, Ryan S Alden, Justin I Odegaard, et al.International Journal of Radiation Oncology, Biology, Physics|October 26, 2005
Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancerHarold J Burstein, Jennifer R Bellon, Sharon Galper, et al.Pageof 68